
Releases
Rosen Law Firm Initiates Class Action Against GeneDx Holdings
Investors who purchased GeneDx Holdings Corp. common stock between April 16, 2025, and May 4, 2026, face a critical deadline to participate in a securities class action lawsuit. Rosen Law Firm has opened the window for potential lead plaintiffs to petition the court by August 3, 2026, seeking recovery for alleged financial misrepresentations.












/bmi/media/post_banners/685374a708a95156958d6658a6e64c51d2d6e73262d48b69d1988c2ac58cb616.jpg)












